A recent study from Gentofte University Hospital in Denmark suggests that using medical marijuana for chronic pain might ...

Debunking claims of safety concerns around Zoetis Inc.'s OA pain drug, Librela. Click here for our updated look at ZTS stock ...

One week after the fatal shooting of UnitedHealthcare CEO Brian Thompson pushed health insurance horror stories to the forefront, people living with chronic pain are now speaking out. That’s due ...

Mumbai: Mumbai’s Brihanmumbai Electric Supply and Transport (BEST) undertaking is facing a major challenge as its bus fleet dwindles, sparking concerns among workers, activists, and commuters.

As more evidence mounts to support the amygdala’s hyperactive threat response as a root cause of chronic pain, healthcare providers are now researching drug-free treatments options that ...

As a chronic condition that impairs the body's ability to regulate blood glucose levels, diabetes requires ongoing medication to prevent severe complications, fueling the growth of the diabetes drug ...

Widespread uptake of the drugs could help tackle the rising tide of chronic diseases across the world and lower the costs associated with them for health systems. In one example, Airfinity ...

As Mangione grew older, his life became more disrupted. Cognitive problems, as well as chronic back pain, became the norm by his mid-20s. “The people around you probably won’t understand your ...

Scientists at Weill Cornell Medicine and the Burke Neurological Institute have developed a groundbreaking drug that may provide relief for people suffering from chronic nerve pain, a condition ...

Administering D₂O to pre-clinical models, the team successfully reduced both acute and chronic inflammatory ... alternative to traditional pain medications, circumventing issues related to ...

has granted Orphan Drug designation to BRC-002 for the treatment of complex regional pain syndrome (CRPS). CRPS is a chronic condition that results in severe pain usually following an injury such ...

Dublin, Dec. 06, 2024 (GLOBE NEWSWIRE) -- The "Chronic Pseudomonas Aeruginosa Pulmonary Infections - Pipeline Insight, 2024" has been added to ResearchAndMarkets.com's offering. This report provides ...